CSL Limited
Australian biotechnology company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about CSL Limited?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications.[3] The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994.
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
This article is about Australian biotech company. For other companies named CSL, see CSL (disambiguation).
Quick Facts Company type, Traded as ...
Company type | Public |
---|---|
| |
Industry | Biotechnology |
Founded | 1916 (Federal government department), 1994 (privatised) |
Headquarters | Parkville, Melbourne, Victoria, Australia (Global),[1] |
Key people | Paul McKenzie (CEO) |
Products | blood plasma, vaccines, antivenom, other laboratory and medical products |
Revenue | US$10.61 billion (2021))[2] |
US$1.919 billion (2021)[2] | |
Number of employees | 30,000 person (2021)[2] |
Divisions |
|
Website | www |
Close